呼吸器疾患検査市場：製品別、用途別-2025-2030年の世界予測

呼吸器疾患検査市場は、2023年に40億8,000万米ドルと評価され、2024年には42億6,000万米ドルに達すると予測され、CAGR 4.43％で成長し、2030年には55億3,000万米ドルに達すると予測されています。

呼吸器疾患検査には、呼吸器系に影響を及ぼす感染症や慢性疾患を特定するために使用される幅広い診断方法が含まれます。喘息、COPD、結核、COVID-19のような疾患の発見に不可欠なスパイロメトリー、血液ガス分析、画像診断、分子診断のような様々な検査が含まれます。これらの検査は、効果的な疾病管理、早期診断、治療の個別化に不可欠であり、ヘルスケアプロバイダーと患者の両方に影響を与えます。公害、ライフスタイルの変化、高齢化により世界的に呼吸器疾患の有病率が高まる中、正確で効率的な検査ソリューションへの需要が高まっています。主な成長要因としては、診断における技術的進歩、ヘルスケア支出の増加、早期診断の利点に対する意識の高まりなどが挙げられます。さらに、COVID-19の大流行は、迅速で信頼性の高い呼吸器検査の必要性を強調し、市場の大幅な拡大と技術革新を促しています。個別化された予測的洞察を提供するリアルタイム分析のためのポイントオブケア検査機器と統合AIツールの開発にビジネスチャンスがあります。しかし、市場の拡大は、規制上のハードル、高度な診断ツールの高コスト、高度な検査機器を操作する熟練した専門家の必要性によって課題となっています。また新興国は、ヘルスケアのインフラが限られているため、制約にも直面しています。携帯可能で侵襲性の低い検査方法に焦点を当て、デジタルヘルスソリューションを統合し、より正確な診断のためのバイオマーカーに関する調査を実施することで、イノベーションを促進することができます。市場は、技術の絶え間ない進化と効率的な診断ソリューションに対する高い需要に牽引され、ダイナミックな動きを見せています。利害関係者は、こうした進歩を活用するための研究開発への投資、市場への浸透を高めるための戦略的パートナーシップの採用、新たな機会を効果的に活用するための規制基準の遵守を徹底する必要があります。コストの削減とアクセシビリティの向上に重点を置くことで、市場への参入を大幅に促進し、既存の課題に対処することができます。

市場力学：急速に進化する呼吸器疾患検査市場の主要市場インサイトを公開

呼吸器疾患検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 呼吸器系疾患の増加
  • タバコの喫煙など、不健康なライフスタイルや習慣の定着
  • 大気汚染レベルの絶え間ない上昇
  • 診断のための画像技術の主な採用
• 市場抑制要因
  • 代替システムや代替機器の入手可能性
• 市場機会
  • 遠隔または在宅ケア検査機器への嗜好の高まり
  • 効果的、効率的、迅速な結果を得るための検査方法の研究開発と技術の進歩
• 市場の課題
  • 保険償還政策の欠如

ポーターの5つの力：呼吸器疾患検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：呼吸器疾患検査市場における外部からの影響の把握

外部マクロ環境要因は、呼吸器疾患検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析呼吸器疾患検査市場における競合情勢の把握

呼吸器疾患検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス呼吸器疾患検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、呼吸器疾患検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨呼吸器疾患検査市場における成功への道筋を描く

呼吸器疾患検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 呼吸器疾患の発生率上昇
    • 喫煙などの不健康なライフスタイルや習慣の採用
    • 大気汚染レベルは継続的に上昇している
    • 診断のための画像技術の大規模な導入
  • 抑制要因
    • 代替システムおよびデバイスの可用性
  • 機会
    • 遠隔または在宅ケア検査機器の好感度が高まっている
    • 効果的、効率的、迅速な結果を得るためのテスト方法の研究開発と技術の進歩
  • 課題
    • 支援的な償還ポリシーの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 呼吸器疾患検査市場：製品別

• 血液ガス検査
• 画像検査
• 呼吸測定

第7章 呼吸器疾患検査市場：最終用途別

• 臨床検査室
• 病院
• 医師クリニック

第8章 南北アメリカの呼吸器疾患検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の呼吸器疾患検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの呼吸器疾患検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biomerieux
• Cosmed
• F. Hoffmann-La Roche Ltd.
• Fujifilm Holdings
• GE Healthcare
• Hitachi Medical Corporation
• Koninklijke Philips N.V
• Medtronic PLC
• MGC Diagnostics Corporation by Caire Inc.
• ResMed
• SDI Diagnostics, Inc.
• Seegene Inc.
• Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. RESPIRATORY DISEASE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. RESPIRATORY DISEASE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. RESPIRATORY DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RESPIRATORY DISEASE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RESPIRATORY DISEASE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. RESPIRATORY DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Respiratory Disease Testing Market was valued at USD 4.08 billion in 2023, expected to reach USD 4.26 billion in 2024, and is projected to grow at a CAGR of 4.43%, to USD 5.53 billion by 2030.

Respiratory disease testing encompasses a broad range of diagnostic methods used to identify infections and chronic conditions affecting the respiratory system. The scope includes various tests like spirometry, blood gas analysis, imaging, and molecular diagnostics, imperative in detecting ailments such as asthma, COPD, tuberculosis, and COVID-19. These tests are essential for effective disease management, early diagnosis, and treatment personalization, impacting both healthcare providers and patients. With an increasing prevalence of respiratory diseases globally due to pollution, lifestyle changes, and aging populations, the demand for accurate and efficient testing solutions is escalating. Key growth influencers include technological advancements in diagnostics, rising healthcare expenditure, and increased awareness of early diagnosis benefits. Moreover, the COVID-19 pandemic has underscored the necessity for rapid and reliable respiratory testing, prompting substantial market expansion and innovation. Opportunities lie in the development of point-of-care testing devices and integrated AI tools for real-time analytics, providing personalized and predictive insights. However, market expansion is challenged by regulatory hurdles, the high cost of advanced diagnostic tools, and the need for skilled professionals to operate sophisticated testing equipment. Emerging economies also face constraints due to limited healthcare infrastructure. Innovation can thrive by focusing on portable and less invasive testing methods, integrating digital health solutions, and conducting research on biomarkers for more precise diagnostics. The market is dynamic, driven by the constant evolution of technology and the high demand for efficient diagnostic solutions. Stakeholders need to invest in R&D to leverage these advances, adopt strategic partnerships to enhance market penetration, and ensure compliance with regulatory standards to capitalize on emerging opportunities effectively. The emphasis on reducing costs and improving accessibility can significantly enhance market reach and address existing challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Disease Testing Market

The Respiratory Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of respiratory diseases
  • Adoption of unhealthy lifestyle and habits such as tobacco smoking
  • Constantly rising air pollution levels
  • Major adoption of imaging technology for diagnostics
• Market Restraints
  • Availability of alternatives systems and devices
• Market Opportunities
  • Rising preferences for remote or home care testing devices
  • R&D and technology advancements in testing methods for effective, efficient, and faster results
• Market Challenges
  • Lack of supportive reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Disease Testing Market

A detailed market share analysis in the Respiratory Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Respiratory Disease Testing Market

A strategic analysis of the Respiratory Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Disease Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux, Cosmed, F. Hoffmann-La Roche Ltd., Fujifilm Holdings, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips N.V, Medtronic PLC, MGC Diagnostics Corporation by Caire Inc., ResMed, SDI Diagnostics, Inc., Seegene Inc., and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Respiratory Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Gas Test, Imaging Tests, and Respiratory Measurement.
• Based on End-Use, market is studied across Clinical Laboratories, Hospitals, and Physician Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of respiratory diseases
    • 5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
    • 5.1.1.3. Constantly rising air pollution levels
    • 5.1.1.4. Major adoption of imaging technology for diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternatives systems and devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising preferences for remote or home care testing devices
    • 5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of supportive reimbursement policies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Respiratory Disease Testing Market, by Product

• 6.1. Introduction
• 6.2. Blood Gas Test
• 6.3. Imaging Tests
• 6.4. Respiratory Measurement

7. Respiratory Disease Testing Market, by End-Use

• 7.1. Introduction
• 7.2. Clinical Laboratories
• 7.3. Hospitals
• 7.4. Physician Clinics

8. Americas Respiratory Disease Testing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Respiratory Disease Testing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Respiratory Disease Testing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories, Inc.
• 4. Biomerieux
• 5. Cosmed
• 6. F. Hoffmann-La Roche Ltd.
• 7. Fujifilm Holdings
• 8. GE Healthcare
• 9. Hitachi Medical Corporation
• 10. Koninklijke Philips N.V
• 11. Medtronic PLC
• 12. MGC Diagnostics Corporation by Caire Inc.
• 13. ResMed
• 14. SDI Diagnostics, Inc.
• 15. Seegene Inc.
• 16. Thermo Fisher Scientific